Literature DB >> 19438850

Lichen planus and dyslipidaemia: a case-control study.

J Dreiher1, J Shapiro, A D Cohen.   

Abstract

BACKGROUND: Previous reports have demonstrated an association between psoriasis and dyslipidaemia.
OBJECTIVES: As lichen planus (LP) is also a chronic inflammatory disorder, we investigated the association between LP and dyslipidaemia in Israel.
METHODS: A case-control study was performed utilizing the database of Clalit Health Services, a large healthcare provider organization in Israel. Patients aged 20-79 years who were diagnosed as having LP were compared with a sample of enrollees without LP regarding the prevalence of dyslipidaemia. Data on other health-related lifestyle factors and comorbidities were collected.
RESULTS: The study included 1477 patients with LP and 2856 controls without LP. The prevalence of dyslipidaemia was significantly higher in patients with LP (42.5% vs. 37.8%, P = 0.003; odds ratio, OR 1.21, 95% confidence interval, [CI]: 1.06-1.38). A multivariate logistic regression model demonstrated that LP was significantly associated with dyslipidaemia even after controlling for confounders, including age, sex, smoking, hypothyroidism, diabetes, hypertension, socioeconomic status and obesity (multivariate OR 1.34, 95% CI: 1.14-1.57, P < 0.001).
CONCLUSIONS: In the present study, LP was found to be associated with dyslipidaemia.

Entities:  

Mesh:

Year:  2009        PMID: 19438850     DOI: 10.1111/j.1365-2133.2009.09235.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  25 in total

1.  Metabolic Derangements in Lichen Planus - A Case Control Study.

Authors:  Bikash Ranjan Kar; Maitreyee Panda; Nibedita Patro
Journal:  J Clin Diagn Res       Date:  2016-11-01

2.  Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India - a descriptive study.

Authors:  Bhuvana Krishnamoorthy; Suma Gn; Mamatha N S; Sowbhagya M B; Komali Garlapati
Journal:  J Clin Diagn Res       Date:  2014-11-20

3.  The Relationship between Lichen Planus and Carotid Intima Media Thickness.

Authors:  Koseoglu C; Erdogan M; Koseoglu G; Kurmus O; Ertem Ag; Efe Th; Kurmus Gi; Durmaz T; Keles T; Bozkurt E
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

4.  Comparison of serum lipid parameters between patients with classic cutaneous lichen planus and oral lichen planus.

Authors:  Ozlem Ozbagcivan; Sevgi Akarsu; Fatma Semiz; Emel Fetil
Journal:  Clin Oral Investig       Date:  2019-05-25       Impact factor: 3.573

5.  Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides.

Authors:  Fatma Pelin Cengiz; Nazan Emiroglu
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

Review 6.  Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis.

Authors:  Farzam Gorouhi; Parastoo Davari; Nasim Fazel
Journal:  ScientificWorldJournal       Date:  2014-01-30

7.  Increased P-wave dispersion in patients with newly diagnosed lichen planus.

Authors:  Musa Sahin; Serap Gunes Bilgili; Hakki Simsek; Serkan Akdag; Aytac Akyol; Hasan Ali Gumrukcuoglu; Mehmet Yaman; Yasemin Bayram; Ayse Serap Karadag
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

8.  Metabolic syndrome and skin: psoriasis and beyond.

Authors:  Tanmay Padhi
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

9.  Is there a relationship between left atrium size and p-wave dispersion in patients with lichen planus?

Authors:  Bilge Bulbul Sen; Emine Nur Rifaioglu; Ali Erayman; Nihat Sen
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

10.  Alterations in Lipid Metabolism and Antioxidant Status in Lichen Planus.

Authors:  Falguni H Panchal; Somshukla Ray; Renuka P Munshi; Supriya S Bhalerao; Chitra S Nayak
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.